Broad Institute Names First Board of Directors | GenomeWeb

NEW YORK (GenomeWeb News) – The Broad Institute of MIT and Harvard has taken its last step, but a significant one, in its year-long transition to a permanent, independent nonprofit by naming its first board of directors, a 14-member panel that will help shape the scientific direction of the genomic medicine research institute, as well as oversee its finances.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.